Asymptomatic isolated microscopic haematuria: Long term follow-up

QJM: An International Journal of Medicine

Volumn 97, Issue 11, 2004, Pages 739-745

  Chow, K M ^a   Kwan, B C ^a   Li, P K ^a   Szeto, C C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BLADDER CARCINOMA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TRANSITIONAL CELL CARCINOMA;

EID: 7744243935     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch125     Document Type: Article

References (30)

1. Cohen RA, Brown RS. Microscopic hematuria. N Engl J Med 2003; 348:2330-8.
2. Tomson C, Porter T. Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence. BJU Int 2002; 90:185-98.
3. Greene LF, O'Shaughnessy EJ. Clinical importance of microhematuria. JAMA 1979; 241:149-50.
4. Sutton JM. Evaluation of hematuria in adults. JAMA 1990; 263:2475-80.
5. Malmström P. Time to abandon testing for microscopic haematuria in adults? Br Med J 2003; 326:813-15.
6. Michael J, Jones NE, Davies DR, Tighe JR. Recurrent haematuria: role of renal biopsy and investigative morbidity. Br Med J 1976; 1:686-8.
7. Glassock RJ. Hematuria and proteinuria. In: Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennelle JC, eds. Primer on kidney diseases, 3rd edn. San Diego, Academic Press, 2001:38-46.
8. Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the Americal Urological Association best practice policy-part I: definition, detection, prevalence, and etiology. Urology 2001; 57:599-603.
9. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 1989; 141:350-5.
10. Grossfeld GD, Wolf JS Jr, Litwin MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Asymptomatic microscopic hematuria in adults: summary of the AUA Best Practice Policy recommendations. Am Fam Physician 2001; 63:1145-54.
11. Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association Best Practice Policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001; 57:604-10.
12. Ringsrud KM, Linné JJ. Microscopic examination of the urine sediment. In: Ringsrud KM, Linné JJ, eds. Urinalysis and body fluids: a color text and atlas, 1st edn. St. Louis, MO, Mosby-Year Book, 1995:81-90.
13. Kohler H, Wander E, Brunck B. Acanthocyturia: a characteristic marker for glomerular bleeding. Kidney Int 1991; 40:115-20.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-70.
16. Levy AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139 137-47.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
19. Leung NW. Patterns of viral hepatitis in Hong Kong. Br J Hosp Med 1997; 58:166-9.
20. Froom P, Froom J, Ribak J. Asymptomatic microscopic hematuria - is investigation necessary? J Clin Epidemiol 1997; 50:1197-200.
21. Froom P, Ribak J, Benbassat J. Significance of microhaematuria in young adults. Br Med J 1984; 288:20-2.
22. Topham PS, Harper SJ, Furness PN, Harris KP, Walls J, Feehally J. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 1994; 87:329-35.
23. de Caestecker MP, Ballardie FW. Unexplained haematuria may be due to slowly progressive glomerular disease. Br Med J 1990; 301 1171-2.
24. Nieuwhof C, Doorenbos C, Grave W, de Heer F, de Leeuw P, Zeppenfeldt E, van Breda Vriesman PJ. A prospective study of the natural history of idiopathic non-proteinuric hematuria. Kidney Int 1996; 49:222-5.
25. Paone DB, Meyer LE. The effect of biopsy on therapy in renal disease. Arch Intern Med 1981; 141:1039-41.
26. Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996; 45:281-8.
27. Syrjänen J, Mustonen J, Pasternak A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15:34-42.
28. Ohno I, Hosoya I, Gomi H, Ichida K, Okabe H, Hikita M. Serum uric acid and renal prognosis in IgA nephropathy. Nephron 2001; 87:333-9.
29. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24:691-7.
30. Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, Odaka M, Yamaguchi M, Yosida H, Morisawa H, Murayama T. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000; 10:403-9.